# AI for Labeling & Regulatory Intelligence

Pharmaceutical companies operate across dozens of regulatory jurisdictions, each with evolving requirements, guidances, and policy interpretations. Keeping track of changes that affect your products — from new safety labeling requirements to shifts in clinical trial endpoint expectations — is a massive ongoing effort.

The Regulatory Intelligence Challenge

A mid-size pharma company with products in 40 markets must monitor: - FDA Federal Register notices, guidances, and advisory committee meetings - EMA scientific guidelines, CHMP opinions, and procedural updates - ICH guideline revisions and implementation timelines - National agency updates (PMDA, TGA, Health Canada, NMPA, and more) - WHO prequalification updates for products in emerging markets

The volume is staggering. The FDA alone publishes hundreds of guidances and thousands of Federal Register notices annually. Missing a relevant change can result in non-compliance, delayed submissions, or rejected applications.